Grifols, S.A. (GRFS) Social Stream



Grifols, S.A. (GRFS): $18.70

1.05 (+5.95%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Featured Post From StockTwits About GRFS

$RIGL
Long-term Safety of Fos in Treating ITP & RA effective - Pg 103

As both Rigel and $GRFS have put their monikers on this report I now realize that Rigel shall soon be coming out with something on Fos for RA.

This study demonstrated markedly improved hemoglobin levels- R2 for wAIHA - pg 65

https://di9mr54a05a64.cloudfront.net/api-bsh.expoplatform.com/files/BJHaem%202021.pdf
Gerszon, published May 30, 2021

What Else are GRFS Traders Talking About?


Other tickers frequently mentioned alongside GRFS is RIGL.

Other Notable StockTweets About GRFS


$RIGL
$RIGL $GRFS Off label usage of #fostamatinib in the EU.
" From professionals perspective, off-label prescription is sometimes inevitable and it might be reinforced by the pressure of patients asking access to a certain therapy. "
https://www.pharmaworldmagazine.com/eu-commissions-report-on-the-off-label-use-of-pharmaceuticals/#:~:text=Off%2Dlabel%20use%20of%20medicines%20is%20theoretically%20prohibited%20according%20to,product%20in%20the%20European%20market.

Gerszon, published May 11, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5925 seconds.